login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
VINCERX PHARMA INC (VINC) Stock News
USA
- NASDAQ:VINC -
US92731L3042
-
Common Stock
0.1
USD
-0.03 (-24.98%)
Last: 4/22/2025, 8:00:01 PM
0.0639
USD
-0.04 (-36.1%)
After Hours:
4/22/2025, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
VINC Latest News, Press Relases and Analysis
All
Press Releases
7 months ago - By: Benzinga
- Mentions:
TTNP
LIXT
AKTX
SNOA
...
12 Health Care Stocks Moving In Tuesday's After-Market Session
7 months ago - By: Benzinga
- Mentions:
SCLX
IBIO
AHG
PRTG
...
12 Health Care Stocks Moving In Tuesday's Intraday Session
7 months ago - By: Vincerx Pharma, Inc.
Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC
7 months ago - By: Vincerx Pharma, Inc.
Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities
8 months ago - By: Vincerx Pharma, Inc.
Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI
9 months ago - By: Vincerx Pharma, Inc.
Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives
10 months ago - By: Vincerx Pharma, Inc.
Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258
Please enable JavaScript to continue using this application.